Zobrazeno 1 - 7 of 7 pro vyhledávání: '"R. J. B. Driessen"'
1
Adalimumab therapy for psoriasis in real-world practice: efficacy, safety and results in biologic-naïve vs. non-naïve patients
Autor: P P M, van Lümig, P C M, van de Kerkhof, J B M, Boezeman, R J B, Driessen, E M G J, de Jong
Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV. 27(5)
Patients and the course of treatment in daily practice are different from randomized controlled trials (RCTs).to analyse the percentage of patients achieving PASI 75.PASI 50, PASI 90, PASI 100 responses, the percentage of patients experiencing at lea
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bb17878dc03e396e41d44c3b09bbcf77
https://pubmed.ncbi.nlm.nih.gov/22416818
Zobrazit plný text záznamu
3
Safety of treatment with biologics for psoriasis in daily practice: 5-year data
Autor: P P M, van Lümig, R J B, Driessen, M A M, Berends, J B M, Boezeman, P C M, van de Kerkhof, E M G J, de Jong
Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV. 26(3)
The cumulative exposition to biologics is increasing with prolonged treatment with a certain biologic or consecutive biological treatment. However, long-term safety data are limited available.The aim of this study was to prospectively evaluate the 5-
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f690a1e8c46f72da42cf5c85cfbbdc13
https://pubmed.ncbi.nlm.nih.gov/21435026
Zobrazit plný text záznamu
4
Relevance of laboratory investigations in monitoring patients with psoriasis on etanercept or adalimumab
Autor: P P M, van Lümig, R J B, Driessen, M A M A, Roelofs-Thijssen, J B M, Boezeman, P C M, van de Kerkhof, E M G J, de Jong
Publikováno v: The British journal of dermatology. 165(2)
Guidelines concerning biological treatment of patients with psoriasis recommend different pretreatment and monitoring laboratory panels in variable frequencies to monitor treatment.To investigate the relevance of laboratory investigations in monitori
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a5969f39717a22ba3da83cc587657b33
https://pubmed.ncbi.nlm.nih.gov/21777211
Zobrazit plný text záznamu
5
Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept
Autor: P P M, Van Lümig, L L A, Lecluse, R J B, Driessen, P I, Spuls, J B, Boezeman, P C M, van de Kerkhof, E M G J, De Jong
Publikováno v: The British journal of dermatology. 163(4)
Knowledge on the sequential treatment of psoriasis with biologics with regard to efficacy and safety is sparse. This also applies to the efficacy and safety of adalimumab in patients previously treated with etanercept. The relationship between the re
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::00299a08ce14ec38b027d46d424b1552
https://pubmed.ncbi.nlm.nih.gov/20649798
Zobrazit plný text záznamu
6
The economic impact of high-need psoriasis in daily clinical practice before and after the introduction of biologics
Autor: R J B, Driessen, L A, Bisschops, E M M, Adang, A W, Evers, P C M, Van De Kerkhof, E M G J, De Jong
Publikováno v: The British journal of dermatology. 162(6)
Although costs of biologics are high, effective treatment of patients with psoriasis may reduce the total health care costs, as it may limit the need for hospitalization.To investigate the economic impact of psoriasis, including direct costs, before
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::23591f2827b6209a7d685e57de70f1d6
https://pubmed.ncbi.nlm.nih.gov/20163420
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje